Pharmacokinetics of aztreonam in infected patients.
Pharmacokinetic parameters of aztreonam were determined in 22 patients with severe Gram-negative infections, treated with 0.5 or 1 g tid as an infusion of 30 min duration. Plasma concentrations were determined microbiologically. Most patients had various degrees of renal impairment and they showed a wide variety of age and body weight. The mean calculated volume of distribution was 17.31 or 260 ml/kg. The total plasma clearance correlated well with the creatinine clearance; the mean plasma clearance was 82 ml/min and the extrapolated extrarenal clearance was 9 ml/min. Actually measured half lives of aztreonam varied between 1 h 20 min, in a patient with normal renal function, and 9 h 40 min in a patient with severely impaired renal function. The results differ from predictions by other authors. Based on our results a dosage adjustment schedule for renal impairment is suggested.
Mattie
H
H
Matze-van der Lans
A
A
D000328:Adult; D000368:Aged; D001398:Aztreonam / Q000378:metabolism* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000378:metabolism*; D003404:Creatinine / Q000097:blood; D005260:Female; D006090:Gram-Negative Bacteria; D006207:Half-Life; D006801:Humans; D008297:Male; D008875:Middle Aged
D003404:Creatinine; D001398:Aztreonam